Meridian Bioscience reported $65.68M in Sales Revenues for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbott ABT:US USD 10.09B 319M
Accelerate Diagnostics AXDX:US USD 2.96M 901K
Atrion ATRI:US USD 48.88M 8.59M
Becton, Dickinson and BDX:US USD 4.76B 120M
Bio Rad Laboratories BIO:US USD 680.8M 10.3M
Cerus CERS:US USD 46.34M 1.29M
Meridian Bioscience VIVO:US USD 65.68M 2.1M
Myriad Genetics MYGN:US USD 156.4M 22.9M
Neogen NEOG:US USD 230.03M 97.68M
Orasure Technologies OSUR:US USD 116.46M 36.23M
Quidel QDEL:US USD 783.8M 170.4M
Rockwell Medical RMTI:US USD 18.69M 9K
Sientra SIEN:US USD 22.57M 1.06M
Staar Surgical STAA:US USD 76.05M 5.06M
Thermo Fisher Scientific TMO:US USD 10.68B 293M
Utah Medical Products UTMD:US USD 12.96M 473K